mat2a inhibitor 2

MAT2A inhibitor 2 is an inhibitor of methionine adenosyltransferase 2A (MAT2A).

MAT2A inhibitor 4 is an inhibitor of the catalytic subunit of methionine S-adenosyltransferase-2, which is used in cancer research.

MAT2A inhibitor 1 is an inhibitor of methionine adenosyltransferase 2A (MATA2) (IC50 < l00 nM).

MAT2A inhibitor 3 can be used in the cancer research. MAT2A inhibitor 3 is a inhibitor of methionine adenosyltransferase 2A (MAT2A) with an IC 50 of <200 nM [1].

MAT2A inhibitor 5 (compound 39) is a selective, orally active, and blood-brain barrier permeable MAT2A inhibitor, demonstrating an IC50 value of 11 nM. In vivo, this compound effectively inhibits tumor cell growth.

MAT2A inhibitor 6 (Compound 3N-h) is a compound renowned for its specificity, oral activity, and yellow fluorescence as a MAT2A inhibitor (IC50=26 nM). It enables visualization of MAT2A both in vitro and in vivo (λex=430 nm, λem= 585 nm). Additionally, MAT2A inhibitor 6 induces apoptosis and possesses anticancer properties, making it useful for cancer research.

MAT2A-IN-2, a potent inhibitor of MAT2A, shows potential for cancer disease research.

MAT2A Allosteric Inhibitor 2 is a potent, selective inhibitor exhibiting an IC50 of 5 nM and demonstrates nanomolar efficacy (IC50 = 5 μM) in proliferation assays utilizing the MTAP -/- cell line [1].